Loading...
XSHE
300049
Market cap1.62bUSD
Oct 09, Last price  
40.49CNY
1D
-1.36%
1Q
-6.38%
Jan 2017
93.27%
IPO
305.71%
Name

Inner Mongolia Furui Medical Science Co Ltd

Chart & performance

D1W1MN
XSHE:300049 chart
P/E
69.37
P/S
6.71
EPS
0.58
Div yield, %
—
Shrs. gr., 5y
0.52%
Rev. gr., 5y
14.55%
Revenues
1.59b
+18.07%
121,590,130126,413,281141,257,489179,975,339210,246,377301,658,211407,639,040523,483,187645,517,668604,191,264826,987,166823,331,334867,029,327831,739,342807,532,607898,483,2281,008,765,8611,153,733,8861,349,015,1801,592,829,219
Net income
154m
+36.02%
22,608,68522,476,59925,816,98434,418,07446,853,13852,490,69641,137,5394,905,38887,235,29891,685,246121,047,93361,114,10635,416,10443,385,85461,905,64695,468,88197,889,814101,563,744113,285,457154,089,068
CFO
354m
+59.95%
49,515,95717,846,52336,473,049-2,095,88049,198,38275,751,89285,883,73228,183,17150,875,669158,159,638148,843,876131,720,83478,347,686256,227,191200,151,631222,552,216189,461,778304,889,062221,408,410354,149,132
Dividend
Jul 06, 20260.15 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Inner Mongolia Furui Medical Science Co., Ltd. functions as a dedicated platform offering specialized healthcare services. The company's primary focus lies in the liver disease sector, where it delivers a full spectrum of solutions encompassing accurate disease diagnosis, pharmaceutical treatments, and ongoing chronic condition management. Beyond this, it also provides comprehensive health management facilities and general medical care services. Established in 1998, with its headquarters situated in Beijing, China, the entity was previously known as Inner Mongolia FuRui Pharmaceutical Limited Liability Company.

Key people

Suiyong Zhang
Vice Chairman of the Board, General Manager · since 2011
Fei Shuo
Deputy General Manager, Director · since 2007
Xinhong Wang
Deputy General Manager · since 2013
Yong Yang
Deputy General Manager · since 2008
Xin Lin
Secretary of the Board, Executive Deputy General Manager, Director · since 2011
Zhanbao Tie
Director · since 2007
Guanyi Wang
Chairman of the Board · since 2011
Jialei Wang
Director · since 2007
Weidong Yu
Vice Chairman of the Board · since 2007
Yiling Zhang
Director · since 2013
Mingliang Cheng
Independent Director · since 2009
Yuyue Hu
Independent Director · since 2007
Xiaodong Zhao
Independent Director · since 2011
Lianyi Xu
Independent Non-Executive Director · since 2026
URL
http://www.fu-rui.com/
IPO date
Jan 20, 2010
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT